Women's health · Live ClinicalTrials.gov data

Elinzanetant clinical trial pipeline

ClinicalTrials.gov lists 7 phase 2–4 trials for elinzanetant, 1 of them actively recruiting. Refreshed daily. Add up to four competitors to compare pipelines side by side.

7

Phase 2–4 trials

4

Phase 3 trials

1

Actively recruiting

2,287

Participants across trials

Bayer

Lead sponsor by trial count

elinzanetant (7)2 active20182031
elinzanetant
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingCompleted
'18
'20
'22
'24
'26
'28
'30
elinzanetant
SWITCH-1P2
OASIS-3P3
OASIS-1P3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)P3
OASIS-4P3
NIRVANAP2
FLASH-CV:P2

Upcoming readouts

1 ahead · elinzanetant

Select a trial to load its full ClinicalTrials.gov record.

Key elinzanetant trials

Top 7 of the 7 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

Track elinzanetant with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track elinzanetant

FAQ

How many clinical trials are running for elinzanetant?
ClinicalTrials.gov currently lists 7 phase 2–4 elinzanetant trials: 3 phase 2, 4 phase 3, and 0 phase 4. 1 are actively recruiting.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare elinzanetant against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.